A novel technique to assay adducts of DNA induced by anticancer agent cis-diamminedichloroplatinum(II).

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Bioconjugate chemistry

• Publication date

  1991-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BC00012A004PMID 1805936
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of laser-induced fluorescence detection to assay DNA damage

  1991cited by this paper
• Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA.

  1991cited by this paper
• Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody.

  1991cited by this paper
• Characterization of cisplatin adducts of oligonucleotides by fast atom bombardment mass spectrometry.

  1991cited by this paper
• Sequence preferences of DNA interstrand cross-linking agents: Importance of minimal DNA structural reorganization in the cross-linking reactions of mechlorethamine, cisplatin and mitomycin C

  1991cited by this paper
• 32P-postlabelling of 7-methyl-dGMP ring-opened 7-methyl-dGMP and platinated dGpdG.

  1990cited by this paper
• Characterization of the DNA damage recognized by an antiserum elicited against cis-diamminedichloroplatinum (II)-modified DNA.

  1990cited by this paper
• A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates.

  1989cited by this paper
• Synthesis and application of fluorescent labeled nucleotides to assay DNA damage.

  1988cited by this paper
• The measurement of cisplatin-DNA adduct levels in testicular cancer patients.

  1988cited by this paper
• Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy.

  1987cited by this paper
• Synthesis, modification with N-acetoxy-2-acetylaminofluorene and physicochemical studies of DNA model compound d(TACGTA).

  1985cited by this paper
• Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.

  1985cited by this paper
• Immunochemical quantitation of adducts induced in DNA by cis-diamminedichloroplatinum (II) and analysis of adduct-related DNA-unwinding.

  1985cited by this paper
• Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II).

  1983cited by this paper
• The antitumor drug cis-dichlorodiammineplatinum forms an intrastrand d(GpG) crosslink upon reaction with [d(ApGpGpCpCpT)]2

  1982cited by this paper
• Detection and quantification of adducts formed upon interaction of diamminedichloroplatinum (II) with DNA, by anion-exchange chromatography after enzymatic degradation.

  1982cited by this paper
• 32P-labeling test for DNA damage.

  1981cited by this paper
• Cis-diamminedichloroplatinum (II). A new anticancer drug.

  1977cited by this paper
• Review of the current clinical status of platinum coordination complexes in cancer chemotherapy.

  1975cited by this paper
• Inhibitory effects of anti‐tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitro

  1970cited by this paper

• Platinum complexes containing adenine-based ligands: An overview of selected structural features

  2017cites this paper
• DNA Adducts as Biomarkers for Carcinogenesis Analysed by Capillary Electrophoresis and Laser-Induced-Fluorescence Detection

  2004cites this paper
• DETERMINATION OF PLATINUM IN CLINICAL SAMPLES

  2002cites this paper
• Improved 32P-postlabelling assay for the quantification of the major platinum-DNA adducts.

  1997cites this paper
• Detection of Adducts Formed upon Treatment of DNA with Cisplatin and Carboplatin

  1996cites this paper
• Anticancer drugs: an underestimated risk or an underutilised resource in mutagenesis?

  1995cites this paper
• Quantitative analysis of 3'-azido-3'-deoxythymidine incorporation into DNA in human colon tumor cells.

  1995cites this paper
• Capillary electrophoretic separation and laser-induced fluorescence detection of the major DNA adducts of cisplatin and carboplatin.

  1995cites this paper
• DNA Modifications: Investigations by Mass Spectrometry

  1994cites this paper
• Application of high-performance liquid chromatography for recognition of covalent nucleic acid modification with anticancer drugs.

  1993cites this paper
• Capillary electrophoresis of fluoresceinethylenediamine-5'-deoxynucleotides

  1992cites this paper